{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:48:20Z","timestamp":1787042900938,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["2017-I2M-1-001"],"award-info":[{"award-number":["2017-I2M-1-001"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["2018PT32014"],"award-info":[{"award-number":["2018PT32014"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Peking Union Medical College Innovative Team Development Program","award":["2016"],"award-info":[{"award-number":["2016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s40618-020-01224-6","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T16:04:36Z","timestamp":1585238676000},"page":"1453-1461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunocyte density in parathyroid carcinoma is correlated with disease relapse"],"prefix":"10.1007","volume":"43","author":[{"given":"Y.","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"1224_CR1","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/cncr.22599","volume":"109","author":"PK Lee","year":"2007","unstructured":"Lee PK, Jarosek SL, Virnig BA et al (2007) Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109:1736\u20131741. https:\/\/doi.org\/10.1002\/cncr.22599","journal-title":"Cancer"},{"key":"1224_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/0284186x.2017.1306103","volume":"56","author":"EM Ryhanen","year":"2017","unstructured":"Ryhanen EM, Leijon H, Metso S et al (2017) A nationwide study on parathyroid carcinoma. Acta Oncol 56:991\u20131003. https:\/\/doi.org\/10.1080\/0284186x.2017.1306103","journal-title":"Acta Oncol"},{"key":"1224_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cen.13055","volume":"85","author":"S Xue","year":"2016","unstructured":"Xue S, Chen H, Lv C et al (2016) Preoperative diagnosis and prognosis in 40 parathyroid carcinoma patients. Clin Endocrinol 85:29\u201336. https:\/\/doi.org\/10.1111\/cen.13055","journal-title":"Clin Endocrinol"},{"key":"1224_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01162-y","author":"F Saponaro","year":"2019","unstructured":"Saponaro F, Cetani F, Mazoni L et al (2019) Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism? J Endocrinol Investig. https:\/\/doi.org\/10.1007\/s40618-019-01162-y","journal-title":"J Endocrinol Investig"},{"key":"1224_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","volume":"39","author":"F Cetani","year":"2016","unstructured":"Cetani F, Pardi E, Marcocci C (2016) Update on parathyroid carcinoma. J Endocrinol Investig 39:595\u2013606. https:\/\/doi.org\/10.1007\/s40618-016-0447-3","journal-title":"J Endocrinol Investig"},{"key":"1224_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.beem.2018.11.002","volume":"32","author":"AS Salcuni","year":"2018","unstructured":"Salcuni AS, Cetani F, Guarnieri V et al (2018) Parathyroid carcinoma. Best Pract Res Clin Endocrinol Metab 32:877\u2013889. https:\/\/doi.org\/10.1016\/j.beem.2018.11.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1224_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014\u20131022. https:\/\/doi.org\/10.1038\/ni.2703","journal-title":"Nat Immunol"},{"key":"1224_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.tcb.2019.01.003","volume":"29","author":"I Vitale","year":"2019","unstructured":"Vitale I, Sistigu A, Manic G et al (2019) Mutational and antigenic landscape in tumor progression and cancer immunotherapy. Trends Cell Biol 29:396\u2013416. https:\/\/doi.org\/10.1016\/j.tcb.2019.01.003","journal-title":"Trends Cell Biol"},{"key":"1224_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4049\/jimmunol.1790024","volume":"200","author":"PJ Fink","year":"2018","unstructured":"Fink PJ (2018) The cancer immunotherapy revolution: mechanistic insights. J Immunol 200:371\u2013372. https:\/\/doi.org\/10.4049\/jimmunol.1790024","journal-title":"J Immunol"},{"key":"1224_CR10","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.359.6382.1344","volume":"359","author":"PN Kelly","year":"2018","unstructured":"Kelly PN (2018) The cancer immunotherapy revolution. Science 359:1344\u20131345. https:\/\/doi.org\/10.1126\/science.359.6382.1344","journal-title":"Science"},{"key":"1224_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41577-018-0014-6","volume":"18","author":"PK Bommareddy","year":"2018","unstructured":"Bommareddy PK, Shettigar M, Kaufman HL (2018) Integrating oncolytic viruses in combination cancer immunotherapy. Nat Rev Immunol 18:498\u2013513. https:\/\/doi.org\/10.1038\/s41577-018-0014-6","journal-title":"Nat Rev Immunol"},{"key":"1224_CR12","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH, O'Connor RS, Kawalekar OU et al (2018) CAR T cell immunotherapy for human cancer. Science 359:1361\u20131365. https:\/\/doi.org\/10.1126\/science.aar6711","journal-title":"Science"},{"key":"1224_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1365-2559.2011.04001.x","volume":"59","author":"N Talat","year":"2011","unstructured":"Talat N, Diaz-Cano S, Schulte KM (2011) Inflammatory diseases of the parathyroid gland. Histopathology 59:897\u2013908. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.04001.x","journal-title":"Histopathology"},{"key":"1224_CR14","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1073\/pnas.1319742111","volume":"111","author":"Y Shi","year":"2014","unstructured":"Shi Y, Hogue J, Dixit D et al (2014) Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia. Proc Natl Acad Sci USA 111:3092\u20133097. https:\/\/doi.org\/10.1073\/pnas.1319742111","journal-title":"Proc Natl Acad Sci USA"},{"key":"1224_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1530\/eje-17-0277","volume":"177","author":"F Haglund","year":"2017","unstructured":"Haglund F, Hallstrom BM, Nilsson IL et al (2017) Inflammatory infiltrates in parathyroid tumors. Eur J Endocrinol 177:445\u2013453. https:\/\/doi.org\/10.1530\/eje-17-0277","journal-title":"Eur J Endocrinol"},{"key":"1224_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.surg.2018.06.013","volume":"164","author":"A Silva-Figueroa","year":"2018","unstructured":"Silva-Figueroa A, Villalobos P, Williams MD et al (2018) Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery 164:960\u2013964. https:\/\/doi.org\/10.1016\/j.surg.2018.06.013","journal-title":"Surgery"},{"key":"1224_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4158\/ep-2018-0538","volume":"25","author":"Y Hu","year":"2019","unstructured":"Hu Y, Bi Y, Cui M et al (2019) The influence of surgical extent and parafibromin staining on the outcome of parathyroid carcinoma: 20-year experience from a single institute. Endocr Pract 25:634\u2013641. https:\/\/doi.org\/10.4158\/ep-2018-0538","journal-title":"Endocr Pract"},{"key":"1224_CR18","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.ccr-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252\u20137259. https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-0713","journal-title":"Clin Cancer Res"},{"key":"1224_CR19","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00018-018-2997-3","volume":"76","author":"H Prenen","year":"2019","unstructured":"Prenen H, Mazzone M (2019) Tumor-associated macrophages: a short compendium. Cell Mol Life Sci 76:1447\u20131458. https:\/\/doi.org\/10.1007\/s00018-018-2997-3","journal-title":"Cell Mol Life Sci"},{"key":"1224_CR20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1479-5876-9-216","volume":"9","author":"M Heusinkveld","year":"2011","unstructured":"Heusinkveld M, van der Burg SH (2011) Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 9:216. https:\/\/doi.org\/10.1186\/1479-5876-9-216","journal-title":"J Transl Med"},{"key":"1224_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"key":"1224_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061. https:\/\/doi.org\/10.1126\/science.1079490","journal-title":"Science"},{"key":"1224_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing JB, Tanaka A, Sakaguchi S (2019) Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50:302\u2013316. https:\/\/doi.org\/10.1016\/j.immuni.2019.01.020","journal-title":"Immunity"},{"key":"1224_CR24","first-page":"2895","volume":"125","author":"O Wang","year":"2012","unstructured":"Wang O, Wang CY, Shi J et al (2012) Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. Chin Med J 125:2895\u20132901","journal-title":"Chin Med J"},{"key":"1224_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","volume":"29","author":"LA Erickson","year":"2018","unstructured":"Erickson LA, Mete O (2018) Immunohistochemistry in diagnostic parathyroid pathology. Endocr Pathol 29:113\u2013129. https:\/\/doi.org\/10.1007\/s12022-018-9527-6","journal-title":"Endocr Pathol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01224-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-020-01224-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01224-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:21:55Z","timestamp":1616718115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-020-01224-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01224-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Ethics Review Board of Peking Union Medical College Hospital (S-K624). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}